Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 946, pseudogene (RNU6-946P) is a member of the U6 small nuclear RNA pseudogene family. Pseudogenes are genomic DNA sequences similar to normal genes but generally nonfunctional due to mutations or truncations. U6 snRNA is a key RNA component of the spliceosome complex involved in the removal of introns from pre-mRNA during RNA splicing in eukaryotes[1][3]. However, RNU6-946P itself is a pseudogene, meaning it is not expected to produce a functional RNA product or protein[4][5]. Pseudogenes like RNU6-946P can sometimes play roles in gene regulation, such as producing small interfering RNAs (siRNAs) or acting as miRNA decoys, but there is no direct evidence for these functions in RNU6-946P specifically[2][6]. RNU6-946P is not a therapeutic target, has no known interacting drugs, and is not reported as a biomarker or disease gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 946, pseudogene (RNU6-946P).